--Indian pharmaceutical group Dr. Reddy's Laboratories is in ongoing talks to buy the anti-smoking aid Nicotinell from Haleon, Sky News reports, citing unnamed sources.

--Financial details regarding how much Dr Reddy's might pay to Haleon--which was spun out of GSK and Pfizer's consumer-healthcare business--remain unclear, but it is unlikely to be as much as the $800 million suggested in a previous report, Sky News reports.

--The companies weren't immediately available for comment.

Full story: https://bit.ly/3HFrAOx

Write to Michael Susin at michael.susin@wsj.com

(END) Dow Jones Newswires

January 16, 2024 08:43 ET (13:43 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.
Grafico Azioni Dr Reddys Laboratories (NYSE:RDY)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Dr Reddys Laboratories
Grafico Azioni Dr Reddys Laboratories (NYSE:RDY)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Dr Reddys Laboratories